An Evaluation of <scp>VYC</scp> ‐17. <scp>5L</scp> for the Treatment of Marionette Lines: A Prospective, Open‐Label, Postmarketing Study
This prospective, open-label study showed that VYC-17.5 L effectively improved marionette lines and was well tolerated.
Authors
- Graeme Kerson (ORCID: https://orcid.org/0009-0004-5988-424X)
- Sofía Ruiz del Cueto
- Fernando Urdiales‐Gálvez (ORCID: https://orcid.org/0000-0001-6913-5278)
- Carola de la Guardia
- Nicola Kefalas
- Alessandro Gritti
Institutions
- Allergan (United Kingdom) (GB)
- AbbVie (Spain) (ES)
- AbbVie (United Kingdom) (GB)
- Instituto de Investigación Biomédica de Málaga (ES)
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1111/jocd.16694
- Citations
- 1
- Primary Topic
- Facial Rejuvenation and Surgery Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.53
Funders
- AbbVie
- Allergan